Publicaciones (230) Publicaciones de María Rosario Isabel Luquin Piudo

2023

  1. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  2. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  3. Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models

    Neurobiology of Disease, Vol. 183

  4. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

  5. Supramolecular nanoreinforced hydrogel provides 3Dinteractions to mesenchymal stem cells and boosts theirpotential in Parkinson’s disease

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. A holistic approach to evaluating Parkinson's disease, using the Delphi method: a linear evaluation index

    Arquivos de Neuro-Psiquiatria, Vol. 80, Núm. 2, pp. 145-152

  2. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

    Translational Neurodegeneration, Vol. 11, Núm. 1

  3. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  4. Hydrogels for brain repair: application to Parkinson’s disease

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 11, pp. 1521-1537

  5. MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

    Diagnostics, Vol. 12, Núm. 1

  6. Neuroinflamación en la enfermedad de Parkinson

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 3, Núm. 1, pp. 14-24

  7. Trial of Prasinezumab in Early-Stage Parkinson's Disease

    New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432

2021

  1. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

    Journal of Parkinson's Disease, Vol. 11, Núm. 1, pp. 187-198

  2. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

    Brain Sciences, Vol. 11, Núm. 3

  3. Interictal amylin levels in chronic migraine patients: A case-control study

    Cephalalgia, Vol. 41, Núm. 5, pp. 604-612

  4. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases

    Neurological Sciences, Vol. 42, Núm. 4, pp. 1473-1482

  5. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

  6. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

  7. Prevalence of Advanced Parkinson’s Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study

    Brain Sciences, Vol. 11, Núm. 12

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3